Results from the Upper Limb International Spasticity Study-II (ULIS-II): a large, international, prospective cohort study investigating practice and goal attainment following treat...

Yazar: Turner-Stokes, Lynne, Fheodoroff, Klemens, Jacinto, Jorge, Maisonobe, Pascal
Baskı/Yayın Bilgisi 2013

Spectrum of practice in the routine management of cervical dystonia with abobotulinumtoxinA: findings from three prospective open-label observational studies

Yazar: Misra, Vijay P., Trosch, Richard M., Maisonobe, Pascal, Om, Savary
Yayımlandı J Clin Mov Disord (2018)

Impact of abobotulinumtoxinA on the clinical features of cervical dystonia in routine practice

Yazar: Trosch, Richard M., Misra, Vijay P., Maisonobe, Pascal, Om, Savary
Yayımlandı Clin Park Relat Disord (2020)

Upper limb international spasticity study: rationale and protocol for a large, international, multicentre prospective cohort study investigating management and goal attainment foll...

Yazar: Turner-Stokes, Lynne, Fheodoroff, Klemens, Jacinto, Jorge, Maisonobe, Pascal, Zakine, Benjamin
Baskı/Yayın Bilgisi 2013

A prospective, observational grouped analysis to evaluate the effect of triptorelin on lower urinary tract symptoms in patients with advanced prostate cancer

Yazar: Gil, Thierry, Aoun, Fouad, Cabri, Patrick, Maisonobe, Pascal, van Velthoven, Roland
Yayımlandı Ther Adv Urol (2015)

Correction to: How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study

Yazar: Colosimo, Carlo, Charles, David, Misra, Vijay P., Maisonobe, Pascal, Om, Savary
Yayımlandı J Neurol (2019)

How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study

Yazar: Colosimo, Carlo, Charles, David, Misra, Vijay P., Maisonobe, Pascal, Om, Savary
Yayımlandı J Neurol (2019)

Composite active range of motion (CX(A)) and relationship with active function in upper and lower limb spastic paresis

Yazar: Bayle, Nicolas, Maisonobe, Pascal, Raymond, Romain, Balcaitiene, Jovita, Gracies, Jean-Michel
Yayımlandı Clin Rehabil (2020)

Factors influencing response to Botulinum toxin type A in patients with idiopathic cervical dystonia: results from an international observational study

Yazar: Misra, Vijay P, Ehler, Edvard, Zakine, Benjamin, Maisonobe, Pascal, Simonetta-Moreau, Marion
Baskı/Yayın Bilgisi 2012

Botulinum Toxin Type A Improves Function According to Goal Attainment in Adults with Poststroke Lower Limb Spasticity in Real Life Practice

Yazar: López de Munain, Lourdes, Valls-Solé, Josep, Garcia Pascual, Irene, Maisonobe, Pascal
Yayımlandı Eur Neurol (2020)

AbobotulinumtoxinA using 2-mL dilution (500 U/2-mL) maintains durable improvement across multiple treatment cycles

Yazar: Dashtipour, Khashayar, Wietek, Stefan, Rubin, Bruce, Maisonobe, Pascal, Bahroo, Laxman, Trosch, Richard
Yayımlandı J Clin Mov Disord (2020)

Factors Influencing Goal Attainment in Patients with Post-Stroke Upper Limb Spasticity Following Treatment with Botulinum Toxin A in Real-Life Clinical Practice: Sub-Analyses from...

Yazar: Fheodoroff, Klemens, Ashford, Stephen, Jacinto, Jorge, Maisonobe, Pascal, Balcaitiene, Jovita, Turner-Stokes, Lynne
Yayımlandı Toxins (Basel) (2015)

Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longi...

Yazar: Turner-Stokes, Lynne, Ashford, Stephen, Jacinto, Jorge, Maisonobe, Pascal, Balcaitiene, Jovita, Fheodoroff, Klemens
Yayımlandı BMJ Open (2016)

Control of IGF-I levels with titrated dosing of lanreotide Autogel over 48 weeks in patients with acromegaly

Yazar: Chanson, Philippe, Borson-Chazot, Françoise, Kuhn, Jean-Marc, Blumberg, Joëlle, Maisonobe, Pascal, Delemer, Brigitte
Baskı/Yayın Bilgisi 2008

Survey of practices employed by neurologists for the definition and management of secondary non-response to botulinum toxin in cervical dystonia

Yazar: Ferreira, Joaquim J., Bhidayasiri, Roongroj, Colosimo, Carlo, Marti, Maria Jose, Zakine, Benjamin, Maisonobe, Pascal
Baskı/Yayın Bilgisi 2013

INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin

Yazar: Misra, Vijay P., Colosimo, Carlo, Charles, David, Chung, Tae Mo, Maisonobe, Pascal, Om, Savary
Yayımlandı J Neurol (2017)

Guided Self-rehabilitation Contracts Combined With AbobotulinumtoxinA in Adults With Spastic Paresis

Yazar: Gracies, Jean-Michel, Francisco, Gerard E., Jech, Robert, Khatkova, Svetlana, Rios, Carl D., Maisonobe, Pascal
Yayımlandı J Neurol Phys Ther (2021)

Tumor Shrinkage With Lanreotide Autogel 120 mg as Primary Therapy in Acromegaly: Results of a Prospective Multicenter Clinical Trial

Yazar: Caron, Philippe J., Bevan, John S., Petersenn, Stephan, Flanagan, Daniel, Tabarin, Antoine, Prévost, Gaëtan, Maisonobe, Pascal, Clermont, Antoine
Baskı/Yayın Bilgisi 2014

Effect of early use of AbobotulinumtoxinA after stroke on spasticity progression: Protocol for a randomised controlled pilot study in adult subjects with moderate to severe upper l...

Yazar: Kong, Keng He, Balcaitiene, Jovita, Berard, Hugues, Maisonobe, Pascal, Goh, Khean Jin, Kumthornthip, Witsanu, Rosales, Raymond L.
Yayımlandı Contemp Clin Trials Commun (2017)

Patient Satisfaction with AbobotulinumtoxinA for Aesthetic Use in the Upper Face: A Systematic Literature Review and Post-hoc Analysis of the APPEAL Study

Yazar: Smit, Riekie, Gubanova, Elena, Kaufman, Joely, Landau, Marina, Molina, Beatriz, Andriopoulos, Bill, Maisonobe, Pascal, Prygova, Inna, Redaelli, Alessio
Yayımlandı J Clin Aesthet Dermatol (2021)